We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ultrasound Control of Genes a Feasible Approach for Bone Regeneration
News

Ultrasound Control of Genes a Feasible Approach for Bone Regeneration

Ultrasound Control of Genes a Feasible Approach for Bone Regeneration
News

Ultrasound Control of Genes a Feasible Approach for Bone Regeneration

Image credit: University of Michigan
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ultrasound Control of Genes a Feasible Approach for Bone Regeneration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Growth factors, or substances like hormones or vitamins that are required for the stimulation of growth within living cells, play a critical role in tissue regeneration.

Without them, many cellular responses fail to be triggered, hindering tissue repair and development, says Mario Fabiilli, Ph.D., a research assistant professor of radiology at the University of Michigan.

“Because growth factors are produced in precisely controlled ways, however, many researchers run into the challenge of developing effective methods for reproducing their patterns in real time,” he says.

This inspired Fabiilli and Renny Franceschi, Ph.D., a professor of periodontics and oral medicine at U-M, to co-lead a team that explored a potential therapy for bone and soft tissue regeneration. Their groundbreaking research was recently published in the journal Biomaterials.

The team, consisting of researchers from a broad range of fields including biomedical engineering and dentistry, found that using high-intensity focused ultrasound, or HIFU, a method approved by the Food and Drug Administration for treating various diseases, can spur tissue regeneration when coupled with genetically modified cells that contain a “gene switch.”

By design, the gene switch controls expression of a molecule, similar to a growth factor. However, Fabiilli and his team’s gene switch was novel because it required both heat shock and a ligand for activation: “When we heated the cells just 5 to 8 degrees Celsius above body temperature in the presence of a specific activating ligand, the gene switch is turned on, thus stimulating gene expression. It was really interesting to observe,” Fabiilli says.

First, the team developed a scaffold that was both biocompatible — or not harmful to living tissue — and easily heated when exposed to HIFU.

For tissue regeneration, delivered cells are commonly encapsulated within a scaffold, which is implanted at the site of the defective tissue. The scaffold, which mimics the extracellular matrix, provides a 3D microenvironment that supports cellular processes involved in tissue regrowth.

“Hydrogels, which are composed of hydrophilic polymers, are a commonly used class of scaffolds,” Fabiilli says. “Due to their high water content, the acoustic attenuation of hydrogels is very low. This means that conventional hydrogels do not heat very efficiently.”

To offset this problem, the researchers needed to develop a composite scaffold with an acoustic attenuation similar to soft tissue.

With this in mind, they developed a composite hydrogel scaffold consisting of fibrin and hydroxyapatite particles. Fibrin, a major component of blood clots, is commonly used for the delivery of cells in tissue regeneration. Hydroxyapatite is the mineral component of bone.

The team then encapsulated cells containing the gene switch, which controlled activation of a firefly luciferase (fLuc) transgene, within the composite scaffolds and the fibrin-only scaffolds. Both versions were simultaneously exposed to varying intensities of HIFU and the activating ligand, which was rapamycin.

Because of the higher attenuation, the composite scaffolds heated more efficiently, which yielded transgene expression. The fibrin-only scaffolds did not demonstrate the same features.

Additionally, the team used bioluminescence imaging to show that fLuc activation could be spatially patterned by moving the focus of the HIFU across the cell-loaded composite scaffolds.

“We were able to maintain that gene expression was controlled within cubic millimeter precision,” Fabiilli says.

Fabiilli and his team also showed that gene activation could be controlled in vivo, or within a living organism.

“We incorporated the cells containing the gene switch-controlling expression fLuc into composite scaffolds and then subcutaneously implanted them into mice,” Fabiilli says. “And interestingly enough, we observed significantly higher rates of expression (using bioluminescence imaging) in the constructs that were exposed to both HIFU and ligand, versus ligand alone.”

Eventually, the team also found that the gene switch could be turned on multiple times, which could be beneficial in promoting tissue regeneration.

“We went back and applied both the HIFU and ligand and observed repeated activation of transgene expression eight days after the initial round,” Fabiilli says. “This was absolutely fascinating and gives way to so many more possibilities when it comes to tissue regrowth.”

This article has been republished from materials provided by the University of Michigan. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference:

Moncion, A., et al. (2019). Spatiotemporally-controlled transgene expression in hydroxyapatite-fibrin composite scaffolds using high intensity focused ultrasound. Biomaterials 194: 14-24

Advertisement